Interdisciplinary Oncology Program

Faculty of Medicine

100-570 West 7th Avenue
Vancouver, British Columbia V5Z 4S6

© 2017 by Kent Chen and Ada Leung. Proudly created with Wix.com

Dr. Francois Benard

François Bénard is the Vice-President, Research at the BC Cancer agency, a distinguished scientist at the BC Cancer Research Center and Professor in the Department of Radiology at the University of British Columbia. He holds the BC Leadership Chair in Functional Cancer Imaging. As a clinician scientist, his research interests are in positron emission tomography (PET), nuclear medicine, cancer imaging and targeted radionuclide therapy. His team developed several new radiopharmaceuticals targeting tumour receptors, notably peptides and small molecule ligands. He initiated the program that developed cyclotron production of 99mTc, now in clinical trials at multiple sites in Canada. He has established extensive multidisciplinary collaborations, and he and his colleagues were awarded the 2015 Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering by NSERC.

Lab website: http://molonc.bccrc.ca/benard-lab/

Email: fbenard@bccrc.ca

Dr. Tim Lee

Dr. Tim Lee received his PhD in computer science in 2001. He is currently a Senior Scientist in Cancer Control Research at the BC Cancer Agency, and an Associate Professor in the Department of Dermatology and Skin Science, University of British Columbia. His research interests include processing and analyzing dermoscopic images and wide-area skin images, developing non-invasive laser speckle techniques for skin cancer detection and determining risk factors of melanoma.

Lab website: http://www.bccrc.ca/dept/cc/tim-lee

Email: tlee@bccrc.ca

Dr. Kuo-Shyan Lin

Dr. Kuo-Shyan Lin studied nuclear engineering (BS) and health physics (MS) at National Tsing Hua University in Hsinchu, Taiwan. He then undertook his doctoral and postdoctoral training in radiochemistry at Johns Hopkins University in Baltimore. After continuing his work as a Research Associate at Brookhaven National Laboratory in New York, and then as an Assistant Professor at University of Pittsburgh, Dr. Lin joined BC Cancer Agency (BCCA) in 2009. He is currently an Assistant Professor in Department of Radiology at University of British Columbia, and a Senior Scientist in BCCA Department of Molecular Oncology. He also heads the Radiochemistry Program at the BCCA Centre of Excellence for Functional Cancer Imaging. Dr. Lin’s research focuses on the development of radiolabeled small molecules, peptides and antibodies for imaging (detection) and radiotherapy of various cancers.

 

Lab website: http://molonc.bccrc.ca/lin-lab/

Email: klin@bccrc.ca

Dr. Calum MacAulay

Dr. Calum MacAulay is currently the Head of the Integrative Oncology Department at the British Columbia Cancer Research Centre (BC Cancer Agency). His group’s motivation is development and translation of technology from basic research into clinically applied procedures. His work focuses on the detection and imaging of early cancers at both the macroscopic and microscopic level using light and its interaction with cells and tissue. He has placed a particular emphasis on cancers of the lung, oral cavity, cervix and prostate. His research interests include the screening and detection of early cancers and the modeling of cancerous processes at multiple space scales (i.e. from the level of individual proteins within cells to the level of an entire region of tissue). He has worked to develop and optimize many types of technology in order to undertake his work (e.g. reflectance and fluorescence spectroscopy, reflectance and fluorescence imaging, confocal microendoscopy, optical coherence tomography, automated image cytometry, quantitative image pathology in absorption and fluorescence microscopy, and high resolution genomic profiling ) much of which have found their way in to clinically used devices.  Some of these devices are already effecting patient outcomes.

Highlights of Dr. MacAulay’s research include his role in bringing the following technologies through invention stages to clinical application: the LIFE device for early lung cancer detection; the VELscope and the Identify for oral cancer/pre-cancer screening, detection, and tumour delineation; and an automated image cytometry approach for lung, oral and cervical cancer screening. All of these approaches are being used clinically in Canada, the US, China, and elsewhere around the world.

Lab website: http://www.bccrc.ca/dept/ic/cancer-imaging/calum-macaulay-phd-1

Email: cmacaula@bccrc.ca   

Please reload

Next Page